A prospective study of G-CSF-primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) study

Blood

Volumn 110, Issue 13, 2007, Pages 4584-4587

  Frangoul, Haydar ^a,l   Nemecek, Eneida R ^b   Billheimer, Dean ^a   Pulsipher, Michael A ^c   Khan, Shakila ^d   Woolfrey, Ann ^e   Manes, Becky ^a   Cole, Catherine ^f   Walters, Mark C ^g   Ayas, Mouhab ^h   Ravindranath, Yaddanapudi ⁱ   Levine, John E ^j   Grupp, Stephan A ^k  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^g CHILDREN S HOSPITAL OAKLAND   (United States)

^h King Faisal Specialty Hospital   (Saudi Arabia)

ⁱ WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^l VANDERBILT UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CD34 SELECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; MALE; MULTICENTER STUDY; MYELOABLATIVE CONDITIONING; NEUTROPHIL; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SAFETY; SCHOOL CHILD; THROMBOCYTE; ADULT; ALLOTRANSPLANTATION; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL COUNT; CHILD; DRUG EFFECT; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; KINETICS; METHODOLOGY; MORTALITY; SURVIVAL;

ADOLESCENT; ADULT; ANTIGENS, CD34; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL COUNT; CHILD; CHILD, PRESCHOOL; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; KINETICS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 39649088491     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-07-101071     Document Type: Article

References (23)

1. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344:175-181.
2. Eapen M, Horowitz MM, Klein JP, et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol. 2004;22:4872-4880.
3. Pulsipher MA, Levine JE, Hayashi RJ, et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant. 2005;35:361-367.
4. Paulin T. Importance of bone marrow cell dose in bone marrow transplantation. Clin Transplant. 1992;6:48-54.
5. Sierra J, Storer B, Hansen JA, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood. 1997;89:4226-4235.
6. Couban S, Messner HA, Andreou P, et al. Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: a study of 29 patients. Biol Blood Marrow Transplant. 2000;6:422-427.
7. Isola LM, Scigliano E, Skerrett D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant. 1997;20:1033-1037.
8. Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood. 2001;98:3186-3191.
9. + cell determination by flow cytometry: International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-226.
10. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
11. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
13. Cox DR. Regression models and life-tables. J Royal Stat Soc Ser B Stat Methodol. 1972;34:187.
14. Spearman C. The proof and measurement of association between two things. Am J Psych. 1904;15:72-101.
15. Brown RA, Adkins D, Khoury H, et al. Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality. J Clin Oncol. 1999;17:806-812.
16. Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation: IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood. 2000;95:3702-3709.
17. Storek J, Gooley T, Siadak M, et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood. 1997;90:4705-4709.
18. Pulsipher MA, Nagler A, Iannone R, Nelson RM. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer. 2006;46:422-433.
19. Diaz MA, Gonzalez-Vicent M, Gonzalez ME, et al. Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH). Bone Marrow Transplant. 2005;36:781-785.
20. Levine JE, Wiley J, Kletzel M, et al. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD. Bone Marrow Transplant. 2000;25:13-18.
21. Watanabe T, Takaue Y, Kawano Y, et al. HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents. Biol Blood Marrow Transplant. 2002;8:26-31.
22. Ringden O, Horowitz MM, Sondel P, et al. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood. 1993;81:1094-1101.
23. Serody JS, Sparks SD, Lin Y, et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant. 2000;6:434-440.